Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Resource for journalists around the world on COVID-19 vaccines 2021-11-22 16:49
Innovent Releases the ORIENT-31 Phase 3 Study First Interim Analysis Results of Sintilimab plus BYVASDA (bevacizumab biosimilar injection) and Chemotherapy in Patients with EGFR-mutated Nonsquamous Non-small Cell Lung Cancer who Progressed After EGFR-TKI Therapy at ESMO Virtual Plenary 2021 2021-11-22 08:16
Innovent Announces Inclusion of the Company's Stock (01801.HK) in the Hang Seng China Enterprises Index 2021-11-22 08:00
CStone Pharmaceuticals and Jiangsu Hengrui Pharmaceuticals announce strategic partnership and exclusive licensing agreement on anti-CTLA-4 monoclonal antibody CS1002 in Greater China 2021-11-21 17:09
CStone Pharmaceuticals and Jiangsu Hengrui Pharmaceuticals announce strategic partnership and exclusive licensing agreement on anti-CTLA-4 monoclonal antibody CS1002 in Greater China 2021-11-21 17:02
Nestle Health Science Partners with Healint to Initiate a Fully Virtual Study on Ketogenic Treatment for Migraines 2021-11-21 08:49
Successful 2020 Tang Prize Award Ceremony Highlights Laureates' Achievements and Influence 2021-11-20 15:00
US FDA Grants Breakthrough Designation for Early-Stage Breast Cancer Detection Blood Test Developed by Datar Cancer Genetics 2021-11-20 08:00
Vela Diagnostics expands automation options for SARS-CoV-2 RT-PCR Test 2021-11-20 01:15
SyneuRx Announces Oral COVID-19 Twindemic Antiviral Drug Candidate Pentarlandir Has Entered Final Portion of FDA Phase II Testing 2021-11-20 01:00
UAE to receive award from Parliamentary Assembly of the Mediterranean for Waterfalls Initiative 2021-11-19 21:33
Brii Biosciences Joins Hang Seng Composite Index 2021-11-19 19:06
Gracell Biotechnologies Granted FDA Orphan Drug Designation for FasTCAR-enabled BCMA/CD19 Dual-targeting CAR-T Cell Therapy Candidate GC012F for the Treatment of Multiple Myeloma 2021-11-19 19:00
YHLO Revealed Its New Development of CLIA Technology at MEDICA 2021 2021-11-19 14:43
111, Inc. Announces Third Quarter 2021 Unaudited Financial Results 2021-11-19 13:31
ASRA 2021 | Cali Biosciences Presents Phase IIa Clinical Data on CPL-01, a Long-Acting Ropivacaine 2021-11-19 13:14
Treating Patients Beyond Borders - Antengene Successfully Hosted Its First R&D Day 2021-11-19 13:00
EQT Infrastructure to acquire Icon Group, Australia's largest integrated cancer care provider 2021-11-19 10:21
Fiji based Omnicare Successfully Adopts the Digital Health Platform Jointly Provided by EnoviQ and InsureMO 2021-11-19 10:00
Investment Confidence in Icon Group to Drive Next Phase of Global Growth With EQT Infrastructure Investment 2021-11-19 09:19
1 319 320 321 322 323 895